Tuesday, February 23, 2016
Rare Disease Day, set for February 29, is intended to raise awareness around the world about rare diseases and their impact on patient lives. Worldwide Clinical Trials will mark the day with a free webcast that demonstrates new perspectives on the study of rare diseases, highlighting the need for the industry to rethink its approach to clinical trial design and execution within this complex area of medicine.
Frenova Renal Research, a drug and medical device contract clinical development services provider dedicated exclusively to renal research, has launched F1RST Up (Frenova Rapid STart Up), an exclusive alliance with recognized leading physician investigators in the nephrology research community.
Gilead Sciences has announced that, effective March 10, current Chairman and CEO John C. Martin, Ph.D. will assume the role of executive chairman of the company. John F. Milligan, Ph.D., currently president and chief operating officer, will be promoted to CEO and appointed to the company’s board of directors.
GuideStar Clinical Trials Management, a company providing support services and strategies for clinical research programs around the U.S., and the Alliance for Clinical Research Excellence and Safety (ACRES), a multi-sector, nonprofit organization building a multi-stakeholder-driven integrated global system for clinical research, have partnered to expand site accreditation and uniformity across the clinical research community to promote and reward excellence.
MediSapiens, a Finnish developer and provider of Bio-IT solutions for research and biomedicine, is a partner in an international consortium aiming at developing personalized medicine applications using integrated genome and other health data. The consortium was founded and is headed by the Competence Centre on Health Technologies of Estonia (CCHT) in the framework of the Competence Centre program supported via Enterprise Estonia. Along with MediSapiens and CCHT, the other consortium members are the University of Tartu Estonian Genome Center (Estonia), Tallinn University of Technology eMedicine Laboratory (Estonia), BioEximi OÜ (Estonia), Duodecim Medical Publications Ltd. (Finland) and Coimbra Genomics (Portugal).
The Alliance for Clinical Research Excellence and Safety (ACRES), a global public-interest collaboration building a comprehensive system to transform clinical research, has announced a major second step toward full implementation of a multi-stakeholder shared information technology platform.